We are live on ! Find out more
DFTX

Definium Therapeutics
DFTX

174 hedge funds and large institutions have $105M invested in Definium Therapeutics in 2021 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 54 increasing their positions, 34 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

129% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 17

59% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 34

18% more call options, than puts

Call options by funds: $7.82M | Put options by funds: $6.62M

12% more funds holding

Funds holding: 155 → 174 (+19)

0.13% more ownership

Funds ownership: 0.74% → 0.87% (+0.13%)

20% less capital invested

Capital invested by funds: $130M → $105M (-$25.5M)

Holders
174
Holders Change
+19
Holders Change %
+12.26%
% of All Funds
3.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
39
Increased
54
Reduced
34
Closed
17
Calls
$7.82M
Puts
$6.62M
Net Calls
+$1.21M
Net Calls Change
-$1.76M

Top Buyers

1
Northern Trust
Northern Trust
Illinois
+$6.83M
2
State Street
State Street
Massachusetts
+$3.34M
3
BlackRock
BlackRock
New York
+$2.87M
4
BB
Busey Bank
Illinois
+$2.35M
5
Goldman Sachs
Goldman Sachs
New York
+$2.14M

Top Sellers

1
Jane Street
Jane Street
New York
-$1.65M
2
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS)
California
-$737K
3
UBS AM
UBS AM
Illinois
-$567K
4
VF
Virtu Financial
New York
-$564K
5
JP Morgan Chase
JP Morgan Chase
New York
-$532K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$38.9M +$2.87M +66,499 +6%
State Street
2
State Street
Massachusetts
$13.1M +$3.34M +77,275 +26%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$6.79M +$579K +13,396 +7%
Northern Trust
4
Northern Trust
Illinois
$6.03M +$6.83M +158,030 +1,083%
Vanguard Group
5
Vanguard Group
Pennsylvania
$4.37M +$598K +13,823 +12%
Millennium Management
6
Millennium Management
New York
$3.24M +$1.01M +23,345 +34%
Susquehanna International Group
7
Susquehanna International Group
Pennsylvania
$2.47M -$510K -11,803 -14%
Goldman Sachs
8
Goldman Sachs
New York
$2.37M +$2.14M +49,479 +271%
Bank of New York Mellon
9
Bank of New York Mellon
New York
$2.06M +$388K +8,966 +18%
BB
10
Busey Bank
Illinois
$1.9M +$2.35M +54,462 New
Charles Schwab
11
Charles Schwab
California
$1.72M +$156K +3,617 +8%
Swiss National Bank
12
Swiss National Bank
Switzerland
$1.72M – – –
AllianceBernstein
13
AllianceBernstein
Tennessee
$783K – – –
Two Sigma Investments
14
Two Sigma Investments
New York
$776K +$960K +22,194 New
MI
15
MMCAP International
Cayman Islands
$759K +$939K +21,720 New
Deutsche Bank
16
Deutsche Bank
Germany
$732K +$74.1K +1,713 +9%
RhumbLine Advisers
17
RhumbLine Advisers
Massachusetts
$716K +$42.9K +992 +5%
Simplex Trading
18
Simplex Trading
Illinois
$680K -$16.7K -387 -3%
Citadel Advisors
19
Citadel Advisors
Florida
$629K -$145K -3,345 -16%
JP Morgan Chase
20
JP Morgan Chase
New York
$603K -$532K -12,306 -59%
CS
21
Credit Suisse
Switzerland
$553K -$2.03K -47 -0.3%
Manulife (Manufacturers Life Insurance)
22
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$537K +$692 +16 +0.1%
New York State Common Retirement Fund
23
New York State Common Retirement Fund
New York
$482K -$199K -4,598 -25%
Invesco
24
Invesco
Georgia
$465K +$135K +3,113 +31%
PCM
25
Penserra Capital Management
California
$456K +$209K +4,841 +59%
1
2 3 4 5

DFTX Hedge Fund Activity: Q3 2021 in Review

174 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Definium Therapeutics (DFTX) for Q3 2021, worth a combined $105M — down 20% from $130M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new DFTX positions and 17 closed out — a net gain of 22 holders — while 54 added to existing stakes and 34 trimmed.

The largest buyer was Northern Trust, adding an estimated $6.83M. The largest seller was Jane Street, cutting an estimated $1.65M.

  • 174 institutional investors held Definium Therapeutics (DFTX) as of Q3 2021, up from 155 in Q2 2021.
  • Funds reported $105M of Definium Therapeutics stock for Q3 2021, down 20% quarter-over-quarter.
  • 39 funds opened new Definium Therapeutics positions in Q3 2021 and 17 closed out, a net change of +22 holders.
  • The largest Definium Therapeutics buyer in Q3 2021 was Northern Trust, an estimated $6.83M added.
  • The largest Definium Therapeutics seller in Q3 2021 was Jane Street, an estimated $1.65M sold.

Based on aggregated 13F filings for Q3 2021.